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Abstract
The field of synthetic biology promises to revolutionize biotechnology through the design of organisms with novel
phenotypes useful for medicine, agriculture and industry. However, a limiting factor is the ability of current methods to
assemble complex DNA molecules encoding multiple genetic elements in various predefined arrangements. We present
here a hierarchical modular cloning system that allows the creation at will and with high efficiency of any eukaryotic
multigene construct, starting from libraries of defined and validated basic modules containing regulatory and coding
sequences. This system is based on the ability of type IIS restriction enzymes to assemble multiple DNA fragments in a
defined linear order. We constructed a 33 kb DNA molecule containing 11 transcription units made from 44 individual basic
modules in only three successive cloning steps. This modular cloning (MoClo) system can be readily automated and will be
extremely useful for applications such as gene stacking and metabolic engineering.
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Introduction
Synthetic biology promises to revolutionize biotechnology by
engineering organisms with novel phenotypes not found in nature.
Applications include the microbial production of chemical
precursors, novel antibiotics and biofuels [1], the creation of
synthetic attenuated viruses for use as vaccines [2] and the
engineering of a minimal free living cell [3].
An element essential for synthetic biology is the ability to
physically assemble complex DNA molecules containing large
numbers of natural or artificial genetic elements. Impressive
progress has been achieved in the past few years with the
development of methods that allow assembly of large pieces of
DNA of up to the size of entire bacterial genomes [4,5,6,7,8]. The
majority of these methods is based on the use of homologous
recombination (both in vivo and in vitro), which provides indepen-
dence from the presence of any restriction sites in the fragments to
assemble. Generation of organisms with novel phenotypes will
however not only require the ability to assemble large pieces of
DNA, but will also need methods that allow generation of many
construct variants for optimization of a desired phenotype. Indeed,
since a desired phenotype cannot be predicted directly from gene
sequences only, development of strains and optimization of
phenotypes will require the ability to generate multiple combina-
tions of various coding sequences as well as many variants of their
regulatory sequences. Such optimization does not necessarily need
to operate at genome scale, and in fact, work currently done for
metabolic engineering already belongs to this type of effort. In this
context, what is needed are methods that allow generation of
constructs or construct libraries containing enough genes for
pathway engineering, i.e. in the size range of 10 to 100 kb. Despite
considerable work done in metabolic engineering in the past few
years, methods currently used for construct assembly are still
limiting, as most of the work is still performed using standard DNA
construction techniques that require extensive planning and
multiple cloning steps.
To make such work more efficient, it is however useful to view
DNA construction not just as a process for assembly of raw pieces
of DNA, but rather as a process that allows assembly of discrete
functional genetic elements. Since synthetic biology can be viewed
as a form of engineering, it should be able to learn from existing
mature technologies such as mechanical engineering. An essential
factor for fast and reliable engineering of complex devices is
standardization of their basic parts. In the case of synthetic
biology, standardization would allow to reuse previously validated
genetic elements from one application to the next, and allow the
free exchange between different users. It should also allow the
development of standardized construct assembly strategies that
would help simplify the planning of cloning strategies and
minimize the number of cloning steps required to obtain a desired
construct.
The first attempt to standardize DNA construction, NOMAD,
was made 15 years ago [9]. The authors proposed that libraries of
modules of defined structure could be built and shared by the
community. NOMAD modules are flanked by sites for the
restriction enzyme StyI, which make them compatible with a
specifically designed destination vector. Modules can be combined
together in any order, but are cloned sequentially one module at a
time to form a composite module, which can then be further
subcloned. A major step forward was the development of the
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biologic parts such as promoter, ribosome binding site and
terminator [10]. Assembly of two basic BioBrick parts results in a
composite part that has the same structure as the basic parts in
terms of flanking restriction sites (the basic and composite parts are
idempotent). This feature allows the same procedure to be
repeated again to obtain larger constructs. Since the first BioBrick
standard, various standards and assembly protocols have been
developed in order to optimize the sequence junctions between
parts or make cloning more efficient [11,12]. However, both
NOMAD and the various BioBrick standards are limited in their
ability to assemble multiple DNA fragments in a single step, and
still rely on procedures that limit their potential for automation
such as extraction of DNA fragments from gels or the requirement
for the design of custom primers for specific constructs [13].
We present here a modular and hierarchical cloning system that
allows any desired eukaryotic multigene construct to be assembled
from sets of pre-made standardized genetic modules, including
promoters, 59 untranslated regions, signal peptides, coding
sequences and terminators. This cloning system is based on the
Golden Gate cloning technology, a method that allows highly
efficient directional assembly of multiple DNA fragments in a
single reaction [14]. In order to prove the general feasibility of this
modular cloning system and to show its potential, a 33 kb
construct encoding 11 transcription units (made from 44
individual basic modules) was generated in only three successive
one-pot cloning steps.
Results
Technological background and general considerations
The principle of Golden Gate cloning is based on the special
ability of type IIS restriction enzymes to cleave outside of their
recognition site [15]. When these recognition sites are placed to
the far 59 and 39 end of any DNA fragment in inverse orientation,
they are removed in the cleavage process, allowing two DNA
fragments flanked by compatible sequence overhangs to be ligated
seamlessly. Since type IIS restriction sites can be designed to create
different overhangs, which are referred to as fusion sites from here
on, directional assembly of multiple fragments is feasible [16]. For
assembly, all DNA fragments can be simply provided as uncut
plasmids, and are combined with the destination vector, T4 DNA
ligase and the type IIS restriction enzyme in a single reaction mix.
The use of restriction-ligation allows the assembly of multiple
fragments with extremely high efficiency: we have shown earlier
that up to 10 DNA fragments can be assembled with 95-100% of
colonies obtained containing the expected construct [14].
We have now developed a general modular cloning strategy
(MoClo) to allow the systematic assembly of complete eukaryotic
transcription units and of multigene constructs from basic pre-
made standardized modules (Fig. 1A). Five basic module types
(level 0 modules) were defined that include promoters, 59
untranslated regions, signal peptides, coding sequences, and
terminators. To enable assembly with the Golden Gate technol-
ogy, each level 0 module type is flanked by specific fusion sites
(Fig. 1B). Fusion sites overlapping with coding sequences were
chosen so as to minimize changes to encoded proteins: the fusion
site at the start codon was chosen to be AATG, while the fusion
site between the signal peptide and the coding sequence was
chosen to be AGGT, with GGT encoding a glycine, which is a
common amino acid in signal peptides at position -1 [17]. Since
the four remaining fusion site sequences (GGAG, TACT, GCTT
and CGCT) are all positioned in non-translated sequences, they
were selected with the only requirements as to be unique and non-
palindromic to guarantee efficient cloning. For cytosolic proteins,
which do not contain a signal peptide, the coding sequence can be
cloned as a module flanked by AATG and GCTT fusion sites
(Fig. 1C); such module type replaces the two modules SP and
CDS of secreted proteins in assembly reactions. Since all level 0
modules from the same type are flanked by identical fusion sites,
they are freely interchangeable, allowing any desired transcription
unit to be created by simply choosing the modules needed. An
assembled transcription unit represents a module again, albeit one
of a higher order (level 1 module), which can be directionally
assembled into a multigene construct (level 2) (Fig. 1A).
Module generation: the level 0 and level 1 modules
In order to allow efficient cloning of the level 0 modules, a set of
level 0 destination vectors was created (Fig 2A). Beside level 0
destination vectors for the five standard elements (pL0-P, pL0-U,
pL0-S, pL0-C and pL0-T) further variants were included to
provide the possibility to clone two or more genetic elements as a
single module, for example promoter and 59 untranslated region
can be cloned as a single module using destination vector pL0-PU
(Fig. 2A). Also, for cytosolic proteins that do not have a signal
peptide, the coding sequence is cloned in vector pL0-SC rather
than in vector pL0-C. All level 0 destination vectors are based on a
pUC19 backbone, confer spectinomycin resistance (Sp
R) and
encode a lacZa fragment for blue/white selection. On both sides of
the lacZa fragment two different type IIS recognition sequences -
here BsaI and BpiI - are positioned in inverse orientation relative
to each other, but creating the identical fusion site as exemplified
by plasmid pL0-P in figure 3. This design allows cloning of the
DNA fragment of interest efficiently via BpiI - removing the BpiI
recognition sites and lacZa in the process - but provides the
possibility to release the cloned fragment with BsaI creating the
identical fusion sites it was cloned in. For cloning of level 0
modules, the designated sequences are PCR-amplified, adding the
respective fusion site and a BpiI recognition site as part of the
primers used for amplification, and cloned via a BpiI Golden Gate
cloning reaction. Any internal type IIS recognition site for
enzymes used in the MoClo system (BsaI, BpiI and later Esp3I)
can be removed from the cloned fragment during this step by
using primers overlapping but containing a single silent nucleotide
mismatch in the recognition site (Fig. 2B).
Compatible sets of sequenced level 0 modules (for example
promoter, 59 untranslated region, signal peptide, CDS and
terminator) are then assembled into a level 1 destination vector
with a second Golden Gate reaction using the enzyme BsaI,
leading to creation of a level 1 module, which contains a
eukaryotic transcription unit (TU1, Fig. 3 and 4A). In contrast to
the level 0 modules, the level 1 destination vectors confer
ampicillin resistance, allowing efficient counter selection against
level 0 module backbones. Similar to the level 0 destination
vectors, a lacZa fragment is flanked on each side by two different
type IIS recognition sites; however, here, the fusion sites defined
by the two type IIS restriction enzymes are not identical (Fig. 3
and 4A). If, as for level 0 destination vectors, the cleavage sites of
the two different type IIS enzymes (BsaI and BpiI) overlapped, all
level 1 modules would be flanked by the same GGAG and CGCT
fusion sites, making further directional cloning impossible.
Therefore a series of 7 level 1 destination vectors was designed
in which the BpiI restriction sites generate two fusion sites with
new specificities for each plasmid (for example sites TGCC and
GCAA for level 1 vector position 1, pL1F-1, Fig. 3, 4A and 5).
These sites are compatible from one vector to the next so that
multiple level 1 modules can be (again) directionally cloned into a
level 2 destination vector. However, to avoid the construction and
Modular Cloning System
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e16765consideration of too many level 1 destination vectors, the spatial
order of overhangs was designed to be circular instead of linear, as
the first fusion site at position 1 (TGCC) is also the final site at
position 7. So a level 1 module for position 1 can be reused later at
a virtual position ‘‘8’’ (Fig. 4B). Due to this design, a maximum of
6 transcription units can be cloned in one step. A second set of
level 1 destination vectors (pL1R-1 to 7, Fig. 5) was also created
for cloning of transcription units in the reverse orientation using
the same sets of level 0 modules. The combination of the two sets
allow cloning of transcription units in either orientation at any
position in level 2 constructs (Fig. 4B), giving the experimenter
maximum freedom of design.
Design of multigene constructs: level 2 and end-linkers
To provide flexibility in the design of multigene level 2
constructs, a set of seven level 2 destination vectors was made
(Fig. 5). All level 2 destination vectors confer resistance to
kanamycin and encode a red color selectable marker (CRed,
containing an artificial bacterial operon responsible for cantha-
xanthin biosynthesis; see Material and Methods) which is
flanked by two BpiI sites. The upstream fusion site of each level 2
destination vector is compatible with the upstream site of a
corresponding level 1 module (for example TGCC in pL2-1). This
design reduces the need for extensive recloning of the same
transcription unit for different positions. For example, a level 1
module made for position 3 can easily be shifted to the relative first
position when the level 2 destination vector pL2-3 is used, virtually
deleting positions 1 and 2 (Fig. 5). The downstream fusion site,
however, is unique to level 2 destination vectors (GGGA). The
connection of the GGGA fusion site with the fusion site of the last
assembled transcription unit in the DNA fragment is then realized
by a set of end-linkers (pELE-n) (Fig. 5). Like the level 1 modules,
the end-linker plasmids confer ampicillin resistance, and the end-
linkers are flanked by BpiI sites. The desired multigene level 2
constructs are then assembled with BpiI from the chosen level 1
modules, a matching end-linker and a level 2 destination vector
(Fig. 3 and 4A).
The use of a basic end-linker (pELE-n), however, limits the
maximal number of transcription units that can be cloned in a
level 2 construct to six, because no type IIS restriction sites are left
in the final construct, preventing further rounds of cloning (Level
2-1 construct; Fig. 4A). To provide an option for the addition of
Figure 1. General overview of the hierarchical and modular cloning system. (A) Libraries of basic (level 0) modules contain cloned and
sequenced genetic elements such as promoters (P), 59 untranslated regions (U), signal peptides (SP), coding sequences (CDS) and terminators (T).
Transcription units are assembled from selected level 0 modules using a one-pot one-step cloning reaction. Multigene constructs are then assembled
in a second cloning step (and optionally further steps) from the transcription units. (B) Level 0 modules of different classes are flanked by compatible
fusion sites. Each fusion site consists of 4 nucleotides of choice (boxed) flanked by a type IIS enzyme recognition site on the left or right side (vertical
box drawn under the fusion site). (C) Examples of assembled transcription units for secreted or cytosolic proteins. The transcription unit for the cytolic
protein was assembled from 4 modules rather than 5, using a CDS module cloned between fusion sites AATG and GCTT.
doi:10.1371/journal.pone.0016765.g001
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designed. These sets, pELB-n and pELR-n, provide two new type
IIS recognition sites (BsaI for pELB-n and Esp3I for pELR-n) and
a color selectable marker (lacZa fragment for pELB-n and CRed
for pELR-n) to the assembled construct. The use of a pELB-n end-
linker rather than a basic end-linker in the first round of assembly
results into a level 2i (intermediate) construct (Level 2i-1; Fig. 4A),
which contains, in addition to the cloned transcription units, two
BsaI restriction sites for a next round of cloning and a lacZa
fragment as selectable marker. The use of a pELR-n end-linker at
the next step would lead to a level 2i-2 construct containing two
Esp3I restriction sites and CRed selectable marker. The alternate
use of end-linkers from the two sets pELB-n and pELR-n for
successive cloning steps allows the process to be repeated
indefinitely from the stand point of the cloning strategy (Fig. 6),
but will ultimately be limited by construct size for transformation
in standard bacterial hosts such as E. coli.
Assembly of 11 transcription units in three steps
To test the system, we cloned a number of level 0 modules,
removing at the same time all internal interfering type IIS
recognition sites from the cloned sequences. These include 11
ORFs representing a wide spectrum of biological functions like
immunoglobulins (IgG1 heavy and light chain), structural viral
Figure 2. Level 0 destination vectors and principle for removal of internal sites from level 0 modules. (A) Level 0 destination vectors.
Level 0 modules are made by amplification of selected sequences with primers adding flanking BpiI sites, and cloning of the amplified fragment
(shown above the horizontal dotted line) via BpiI into the designated level 0 destination vectors (shown below). In addition to the 5 basic destination
vectors, pL0-P, pL0-U, pL0-S, pL0-C and pL0-T, additional destination vectors allow cloning several genetic elements in one module. For example,
plasmid pL0-SC can be used to clone sequences encoding cytosolic proteins, which do not contain a signal peptide. (B) Strategy for removing
internal type IIS recognition sequences. Removal of a BsaI site in a fragment of interest is done by amplifying two fragments with primers pr1 and 2
and primers pr3 and 4. Primers pr2 and pr3 span the BsaI recognition site and introduce a single nucleotide mismatch (indicated by an arrow). As all
primers have BpiI recognition sites in their 59 extensions, the PCR fragments are cloned with a BpiI-based Golden Gate cloning reaction in the
appropriate level 0 destination vector.
doi:10.1371/journal.pone.0016765.g002
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the silencing inhibitor p19, the bar resistance marker and GFP.
Since the number of commonly used promoters and terminator
sequences available for expression of heterologous proteins in
plants is low (our laboratory uses plants as expression host), and to
avoid repetitive sequences in the planned multigene construct, we
also cloned several Arabidopsis thaliana promoter and terminator
sequences from genes which show a high expression level in leaves
[18]. A summary of all level 0 modules used in this study is
presented in Table S1.
Step one: Construction of level 1 modules. As a first step
towards a construct encoding 11 transcription units, the level 0
modules were assembled into 11 artificial transcription units.
Promoters and terminators were randomly assigned to ORFs
without consideration for potential level of expression, since all
constructs described next were made purely as an exercise to
demonstrate the ability of the MoClo system to clone multigene
constructs. The designated transcription units were also randomly
assigned to one of the seven level 1 positions (Fig. 7A). In 11
independent cloning reactions, the level 0 modules were combined
with the respective level 1 destination vectors, T4 DNA ligase and
the restriction enzyme BsaI in a one-tube one-step reaction. The
different antibiotic resistances of level 0 and level 1 destination
vectors used in combination with the blue/white selection provide
a convenient way to screen for correctly assembled level 1
modules. After transformation, the reactions were spread on plates
containing ampicillin and X-Gal and the numbers of white and
blue colonies were counted. The number of white colonies
(expected for the correct constructs) varied from approximately
16,000 to 180,000, whereas a few blue colonies (,1%) were
present in only two out of eleven reactions (constructs level 1 cL1-1
to cL1-11; Fig. 8A). Plasmid DNA from two white colonies from
each reaction were analyzed by an analytical endonuclease
cleavage with BpiI (which cleaves on both sides of the assembled
transcription unit). All 22 tested plasmids contained a fragment of
the expected size (not shown).
Step two: Assembly of up to six level 1 modules into a level
2 construct. As a next step, we analyzed how efficiently
multiple level 1 modules could be assembled into a level 2
construct. Therefore, five BpiI-based Golden Gate cloning
reactions were set up, including two to six level 1 modules, the
appropriate end-linker (pELE-2 to pELE-6) and the level 2
destination vector (pL2-1) (constructs level 2 cL2-1 to cL2-5,
Fig. 8A). The kanamycin resistance and the CRed color selection
marker of the level 2 destination vector permits an effective
counter-selection against the level 1 module plasmids and a red/
white color selection for correctly assembled level 2 constructs.
The number of white colonies obtained per transformation, which
Figure 3. Arrangement of type IIS restriction sites and fusion sites for all assembly levels. A detailed overview of the organization and
orientation of the type IIS restriction sites and the fusion sites at the different levels of the MoClo system is shown. A PCR product containing a
promoter flanked by BpiI recognition sites and promoter-specific fusion sites (highlighted with color) is cloned via BpiI into the level 0 destination
vector pL0-P. The promoter fragment in the resulting level 0 module is still flanked by the same fusion sites, but can now be released with BsaI. The
level 0 promoter module and the other level 0 modules required to form a complete transcription unit (not shown) are then assembled via BsaI into a
level 1 destination vector. As the fusion sites created by BsaI and BpiI do not overlap, the assembled level 1 module (here TU1) is equipped with two
level 1-specific fusion sites (TGCC and GCAA). The level 1 module TU1 and other level 1 modules of choice (TU2 and not shown) can then be
assembled via BpiI into the final level 2 construct in which no type IIS recognition sites are left. n indicates that any nucleotide can be used. CRed, red
color selectable marker; P, promoter module; TU, assembled transcription unit.
doi:10.1371/journal.pone.0016765.g003
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33,000 (for two level 1 modules plus end-linker) to 150 (six level 1
modules plus end-linker), and the percentage of incorrect red
colonies increased from 0.02% to 10% (Fig. 8A and B). Six white
colonies were analyzed from each level 2 construct assembly by
analytical endonuclease cleavage of plasmid DNA and all were
correct (not shown).
As shown above, the assembly of a 24 kb construct (cL2-5)
encoding six transcription units canbe done in a single one-step and
one-tube reaction from level 1 modules. However the final level 2
constructs are in a ‘‘closed’’ status as no type IIS restriction sites are
left, prohibiting the insertion of additional genes. In order to extend
the number of transcription units beyond six, new type IIS
recognition sites have to be incorporated into the level 2 constructs.
Therefore constructs cL2-4 and cL2-5 were recreated, but using
end-linkers pELB-5 and pELB-6 instead of pELE-5 and pELE-6.
These new end-linkers provide two new BsaI restriction sites and a
lacZa fragment to the final constructs cL2-6 and cL2-7. In contrast
to the red/white selection used for pL2-4 and pL2-5, red/blue
selection is used. In addition to correct blue and incorrect red
colonies, dark green colonies were also obtained; these contain
incorrectplasmidswith both theCRed operonanda lacZa fragment
(Fig. 7B). Although the efficiency dropped for the last construct,
correct constructs were obtained for both reactions. The correctly
assembled constructs were used for a further round of assembly.
3
rd step: Assembly of the final 33 kb construct. Level 2i-1
plasmid cL2-6 was chosen as a destination vector for the
introduction of up to six additional transcription units. In
contrast to the previously described assembly steps, two type IIS
restriction enzymes have to be used in the same mix. BsaI reopens
the level 2i-1 backbone and provides defined fusion sites which are
compatible with the level 1 modules released by BpiI. Since two
type IIS restriction enzymes have to be used at the same time and
since the level 2i-1 destination vector cL2-6 has already a size of
20 kb, we tested again the efficiency of the Golden Gate cloning.
One to six additional modules were assembled with the
appropriate end-linkers resulting in constructs cL2-8 to cL2-13.
The cloning efficiency decreased with increasing number of
incorporated modules (Fig. 8A). Interestingly, the rate with which
the cloning efficiency drops is similar to the earlier analyzed set of
Figure 4. Modular cloning strategy. (A) Constructs are assembled by mixing in one tube all module plasmids (or PCR fragments for level 0) and a
destination vector together with the appropriate type IIS enzyme (indicated above the arrows) and ligase. ++ indicates that only one of several
modules was drawn due to space limitation. Each fusion site is shown as a box indicating its 4 nucleotides; the two boxes below show which type IIS
recognition sites flank the fusion sites on the left and/or right sides. P1-a/b, promoter fragment a or b; U, 59 untranslated region; SP, signal peptide;
CDS, coding sequence; T, terminator; CRed, red color selectable marker; LacZ, lacZa fragment, blue color selectable marker; L2E, end-linker 2; Ap
R,
ampicillin resistance; Km
R, kanamycin resistance; Sp
R, spectinomycin resistance. (B) General structure of level 2 constructs. Transcription units are
located between the sequences GGAG and CGCT (remnants of fusion sites used for assembly of transcription units in forward orientation) or AGCG
and CTCC (for transcription units cloned in reverse orientation). The number above the transcription units indicates the relative position of the
transcription units in the final construct (indicates which of the 7 level 1 destination vectors shown in figure 5 was used for assembly of this
transcription unit). The construct is terminated at the right end by an end-linker (EL) that joins the downstream fusion site of the last transcription
unit (NNNN) with the downstream fusion site of the destination vector (GGGA).
doi:10.1371/journal.pone.0016765.g004
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vector size of 22 kb versus 4 kb. In case of the largest construct
(cL2-13), no positive clone was identified. The cloning reaction
was repeated using different Golden Gate cloning conditions with
a program providing alternating cycles optimal for restriction and
ligation. These conditions increased the total number of white
colonies, and all six tested cL2-13* constructs were correct (the
final construct is shown in Fig. 7B).
Figure 5. Vector set required for the MoClo system. All level 1 destination vectors (forward and reverse), level 2 destination vectors and the
different end-linker sets are shown. Dotted arrows indicate the linear relationships between fusion sites in level 1 destination vectors. Compatible
fusion sites are labeled with the same color.
doi:10.1371/journal.pone.0016765.g005
Figure 6. The MoClo cloning principle can be repeated indefinitely. Every cloning step relies on three elements that are different from one
level to the next: antibiotic selectable marker, type IIS enzyme(s), and color selectable marker. Cloning after level 2i-1 requires the simultaneous use of
two type IIS enzymes: BpiI/BsaI or BpiI/Esp3I.
doi:10.1371/journal.pone.0016765.g006
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are functional, we tested expression of GFP from all level 2
constructs (pL2-1 to pL2-13). All were introduced into Agrobacterium
tumefaciens and inoculated into Nicotiana benthamiana. As expected,
GFP under control of a 35S promoter is expressed for all
constructs (Fig. 9).
Discussion
We have shown here that complex constructs containing many
transcription units (here 11, consisting of 44 individual basic
modules) can be assembled by a series of three one-pot Golden Gate
cloning reactions. The construction principle exemplified in this
work can theoretically be repeated indefinitely to add more
transcription units, until the constructs become simply too large to
be transformed or propagated in standard hosts such as E. coli.A s
outlined in figure 6, it is necessary to create a destination vector at
each level 2 cloning step for further rounds of cloning (level 2i-2 to
level 2i-3, etc…). This is done by the alternating use of end-linkers
providing different type IIS restriction sites (for example Esp3I or
BsaI) and allowing convenient color selection from blue to red and
vice versa (Fig. 6). The expansion, for example, of the largest
construct made in this study (cL2-13, level 2-2, 33 kb)would require
its reconstruction, but with an end-linker that adds two Esp3I
restriction sites to the construct (end-linker pELR-4, Fig. 5). One or
more genes could then be added to this level 2i-2 destination vector
using an Esp3I/BpiI Golden Gate cloning reaction (Fig. 6).
Beside the construction of large and complex constructs
encoding entire pathways, the high cloning efficiency also allows
the creation of construct libraries. Instead of using one specific
module for each component of a transcription unit, a module
library can be used instead. In case a library of promoters is used,
constructs obtained would contain a coding sequence under
control of different promoters. Since nearly all constructs are
correct, the library can be screened directly for optimal expression
level for this particular gene, or be used for the next level of
cloning in which several genes or again gene libraries are
assembled. This application is of particular interest for the
optimization of biochemical pathways for metabolic engineering
where several genes not only have to be co-expressed, but also,
their expression ratios have to be balanced to obtain optimal yield
of the desired product.
The advantages of using standardized modules do not lie
exclusively in the ability to easily create complex constructs.
Figure 7. Structure of the eleven level 1 modules (A) and the final level 2 construct cL2-13 (B). All transcription units were assembled
from 5 plasmids: 4 level 0 modules (promoter, 59 untranslated region, CDS, and terminator) and a destination vector. All proteins are cytosolic except
the two from constructs cL1-8 and 9 which are secreted. For both of these, the coding sequence module already contained the signal peptide. LB, T-
DNA left border; RB, T-DNA right border; V, tobacco mosaic virus 59 untranslated region; genetic elements used are listed in Table S1.
doi:10.1371/journal.pone.0016765.g007
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result in tremendous synergistic effects, since the validated
modules or module libraries created by different scientific groups
can be reused from the whole scientific community. An impressive
example is the widely used standard proposed by the BioBrick
foundation [10,19]. Here, researchers from all over the world have
already contributed thousands of compatible modules to a freely
available module collection. In contrast to MoClo, Biobrick
modules are flanked by standard type II restriction enzymes, and
assembly of two BioBricks via restriction and ligation results in an
idempotent new Biobrick module. However, the two modules are
separated by a scar sequence, and the process is unsuitable for the
assembly of multiple fragments in one step.
The principlethat a huge community contributes to a standardized
system requires however that the standard shows some flexibility.
Although the MoClo system described here is based on five basic
modules, it is very versatile since each of these modules can be
subdivided in smaller modules that would still be compatible with the
Figure 8. Cloning efficiency of level 1 and 2 constructs. (A) Assembled transcription units are schematically represented as boxes annotated
with the name of the CDS they contain. Transcription units shown in grey were cloned in the previous step (in construct cL2-6). The respective
cloning position of each transcription unit is indicated on the top. For level 2 constructs, the end-linker is shown as a circle. The number of colonies
obtained per transformation is shown by color type, with the first number corresponding to the expected correct constructs (for cL2-6, wrong clones
could be either red or green). (B) Plates from transformation of constructs for level 2-1 (cL2-2, cL2-4 and cL2-5) and level 2i-1 (cL2-6). Since level 2-1
cloning uses red/white selection, the correct constructs should be white, while colonies containing the original destination vector construct should
be red. Level 2i-1 uses a blue/red selection, with colonies containing correct constructs expected to be blue, whereas incorrect ones can be red or
green (contain both the canthaxanthin operon and the lacZa fragment).
doi:10.1371/journal.pone.0016765.g008
Modular Cloning System
PLoS ONE | www.plosone.org 9 February 2011 | Volume 6 | Issue 2 | e16765existing ones. For example, a terminator can be split in two modules
consisting of 39 untranslated region and actual terminator sequences
by definition of a new fusion site separating both modules. The
transcription unit would be assembled with the two new modules
replacing the original terminator. In case of more sophisticated
cloning applications, like the shuffling of an ORF consisting of several
protein modules, it may be favorable to define an entire new level.
These level -1 modules have to follow the same principles as all other
modules: a set of compatible overhangs, where the first and the last
are compatible to the next level, a specific color selection and a
specific antibiotic selection marker have to be defined.
The data presented here show that all elements required for the
design of a completely automated cloning system are now in place.
Operations that are required for cloning using the MoClo system
consist of preparation of plasmid DNA, liquid handling and
incubation to perform restriction-ligation, plating of transformation
on plates, picking of colonies, and digestion and analysis of plasmid
DNA. The last step can even be replaced by DNA sequencing of a
single colony, because the system is so efficient. A further advantage
in terms of automation is that no sophisticated construction
strategies are needed since the design is automatically defined by
the number and the order of modules that a user wants to assemble.
The cloning strategy can be easily and unambiguously determined
by a simple computer program, which could also be directly linked
to the automation robots that would make the construct.
Materials and Methods
Molecular biology reagents
Restriction enzymes used in this study were purchased from New
England Biolabs (Frankfurt, Germany) and Fermentas (St. Leon-
Rot, Germany). T4 DNA ligase was purchased from Promega
(Mannheim, Germany). Plasmid DNA preparations were made by
using the NucleoSpin Plasmid Quick Pure kit (Macherey-Nagel,
Dueren, Germany) following the manufacturer protocol. Plasmid
DNA concentration was measured using a Nano DropH Spectro-
photometer ND-2000 (Peqlab, Erlangen, Germany).
MoClo cloning protocol
Restriction-ligations were set up by pipetting in one tube
approximately 40 fmol (,100 ng of DNA for a 4 kb plasmid) of
each DNA component (PCR product or plasmid), 10 U of the
required restriction enzyme (BsaI or BpiI) and 10 U T4 DNA
ligase (using high concentration ligase, 20 U/ml) in Promega
ligation buffer in a final reaction volume of 20 ml. The reaction
was incubated in a thermocycler for 5 hours at 37uC, 5 min at
50uC and 10 min at 80uC. The reaction mix was then added to
100 ml chemically competent DH10b cells, incubated for 15–
30 min on ice and transformed by heat shock. 800 ml of liquid LB
was then added to the transformation, and the cells were let to
recover 45 min at 37uC. Different aliquots of the transformation
were plated on LB plates containing the appropriate antibiotic.
The number of colonies was counted for one or two selected plates
(containing countable number of colonies), or from a section of the
plates when very high number of colonies were obtained even for
the lowest volume plated. The number of colonies was then
extrapolated for the entire transformation.
For level 2-2 cloning, two type IIS enzymes were required, BpiI
and BsaI. The same protocol was used as described above except
that 10 U and 2.5 U were used for the enzymes BpiI and BsaI,
respectively. To optimize efficiency of the restriction-ligation for
the final construct containing 11 transcription units (cL2-13*), a
variation of this protocol was used as follows. The reaction mix
was set up containing 20 U ligase, 5 U BpiI and 5 U BsaI, in a total
reaction volume of 20 ml. The mix was incubated in a
thermocycler with the following parameters: incubation for 2
minutes at 37uC, 5 minutes at 16uC, both steps repeated 45 times,
followed by incubation for 5 minutes at 50uC and 10 minutes at
80uC. The reaction mix was transformed in E. coli chemically
competent cells as described above.
Cloning of the canthaxanthin biosynthesis operon
A DNA fragment containing genes for canthaxanthin biosyn-
thesis was made by PCR amplification of 4 genes from Pantoea
ananatis that are necessary for biosynthesis of b-carotene (genes
crtE, crtY, crtI and crtB) [20] and of one gene from Agrobacterium
aurantiacum (crtW) necessary to convert b-carotene to canthaxanthin
[21]. crtW is used in addition to the 4 Pantoea genes because the
orange/red color of canthaxanthin is more visible on agar plates
than the yellow color of b-carotene. The Pantoea ananatis strain was
obtained from the DSMZ (cat. DSM 30080), and a fragment
containing crtW was synthesized by Mr. Gene GmbH (Regens-
Figure 9. Expression of GFP by level 2 constructs. Level 2 constructs in Agrobacterium tumefaciens were inoculated into N. benthamiana leaves.
GFP expression was observed at 5 dpi under UV light. The number in parenthesis indicates the number of transcription units in each infiltrated
construct.
doi:10.1371/journal.pone.0016765.g009
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under control of the P. ananatis native promoter was made by
ligation of three fragments derived from PCR: fragment 1
containing the promoter and crtE was amplified from P. ananatis
genomic DNA with primers 59-ttt ggtctc a ggag ggtaccgcacggtctgc-
caa and 59-ttt ggtctc a tcatgcagcatccttaactgacggcag, fragment 2
containing crtW was amplified from a synthetic DNA fragment
(sequence identical to the native sequence) with primers 59-ttt
ggtctc a atgagcgcacatgccctgcc and 59-ttt ggtctc a tcact-
catgcggtgtcccccttggt, and fragment 3 containing crtY-I-B was
amplified from P. ananatis DNA using primers 59-ttt ggtctc a
gtgacttaagtgggagcggctatg and 59-ttt ggtctc a atgtagtcgctctttaacgat-
gag. The fragments were assembled by Golden Gate cloning in a
target vector using BsaI. Two BpiI and one Esp3I site present in
crtY were removed using primers containing silent mutations in the
recognition sites.
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